tirzepatide for obstructive sleep apnea Weight-loss drug Zepbound resolves in up to 52% of patients, Lilly says 2 Minute Medicine: Pharma Content

This evidence shifted GLP-1 from a diabetes drug with side benefits into a legitimate first-line obesity treatment

Psychological factors, including stress levels and sleep quality, affect metabolic regulation and may modulate treatment outcomes

Superguts $22 million Series B was led by Full Frame Growth Partners, and brought the startups total funding to approximately $36 million

Jan 01, 2025 3 min read Research Article Title Goes Here A brief excerpt from the article introducing the topic and giving the reader a reason to click through and read more

Planning a pregnancy while on tirzepatide Some women reading this are not currently pregnant but want to be

The differentiator is pathway-level genetic insight that maps FTO, GLP1R, and MC4R variants context not offered at Hims, Fella Health, or most other GLP-1 telehealth programs